Single-cell sequencing reveals pre-activated anti-viral innate immunity as control of early SARS-CoV-2 infection in children
Lists
Only you see this
Abstract
<pre>This dataset comprises single-cell RNA-Seq data of nasopharyngeal samples of COVID-19 patients and 16 healthy controls, for a total of 48 samples. 25 COVID-19 patients and 10 controls were diagnosed with hypertension and treated with either ACE inhibitors (ACEi) or angiotensin receptor blockers(ARB) (SARS-CoV-2-positive: 10 ACEi and 15 ARB; SARS-CoV-2-negative: 6 ACEi and 4 ARB).<br>An in-depth description is presented in the manuscript "Delayed viral clearance and exacerbated airway hyperinflammation in hypertensive COVID-19 patients" (https://www.medrxiv.org/content/10.1101/2020.09.22.20199471v1).</pre>
BibTeX
@inproceedings{loske2021single,
author = {Jennifer Loske and Jobst Roehmel and Soeren Lukassen and Sebastian Stricker and Vladimir Gonçalves Magalhães and Johannes Liebig and Robert Lorenz Chua and Loreen Thürmann and Marey Messingschlager and Anke Seegebarth and Bernd Timmermann and Sven Klages and Markus Ralser and Birgit Sawitzki and Leif Erik Sander and Victor M. Corman and Christian Conrad and Sven Laudi and Marco Binder and Saskia Trump and Roland Eils and Marcus Mall and Irina Lehmann},
title = {{Single-cell sequencing reveals pre-activated anti-viral innate immunity as control of early SARS-CoV-2 infection in children}},
booktitle = {Figshare},
year = {2021},
doi = {10.6084/m9.figshare.14938755.v1},
}Loading related content...